Sign Up to like & get
recommendations!
0
Published in 2019 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2019.6476
Abstract: Importance Hematopoietic cell transplantation (HCT) is a therapeutic strategy in the management of several hematological cancers. Limited data exist on the incidence and predictors of 30-day readmission after HCT. Objective To measure the incidence of…
read more here.
Keywords:
allo hct;
readmission;
volume;
factors associated ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2021.6846
Abstract: Importance Matched sibling donors (MSDs) are preferred for allogeneic hematopoietic cell transplantation (allo-HCT) in myelodysplastic syndrome even if they are older. However, whether older MSDs or younger human leukocyte antigen-matched unrelated donors (MUDs) are associated…
read more here.
Keywords:
survival;
free survival;
allo hct;
older msds ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.268
Abstract: Background Recent studies have shown that using absolute lymphocyte count (ALC) based dosing of ATG (anti-thymoglobulin) can improve survival after allogeneic hematopoietic cell transplantation (Allo–HCT). At our center we routinely use a combination of ATG + post-transplant…
read more here.
Keywords:
gvhd prophylaxis;
atg;
allo hct;
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.339
Abstract: Introduction and Objectives Letermovir (LTV) is the first agent in the class of anti-CMV viral terminase inhibitors and was recently approved in the U.S. for the prevention of CMV infection in CMV-seropositive allo-HCT recipients. In…
read more here.
Keywords:
allo hct;
cmv seropositive;
hct recipients;
cmv ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.436
Abstract: Background At our center, we observed a series of patients who developed transudative refractory ascites secondary to non-cirrhotic non-veno-occlusive disease (NC-nVOD) portal hypertension after allogeneic transplant (allo-SCT). The natural history, pathogenesis and etiology of this…
read more here.
Keywords:
portal hypertension;
allo hct;
refractory ascites;
hypertension ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.177
Abstract: Allogeneic hematopoietic transplantation (allo-HCT) causes various pulmonary comorbidities including bronchiolitis obliterans (BO), interstitial pneumonia (IP) and pulmonary infectious disease. Smoking is a well-known risk factor of pulmonary dysfunction such as chronic obstruction pulmonary disease. Although…
read more here.
Keywords:
allogeneic transplantation;
allo hct;
survival outcomes;
transplantation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.491
Abstract: Background Waldenstrom macroglobulinemia (WM) is an indolent IgM-producing lymphoproliferative disorder that remains incurable. Although it is an indolent disease, patients with a high international prognostic scoring system (IPSS)-WM have an overall survival (OS) of less…
read more here.
Keywords:
heterogeneity;
allo hct;
transplantation;
meta analysis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.634
Abstract: Background Allogeneic hematopoietic stem cell transplant (HCT) is a potentially curative treatment modality for patients with AML. However, the success of transplant is limited by transplant-related mortality. Post-transplant complications have been linked to endothelial damage…
read more here.
Keywords:
allo hct;
patients aml;
hct;
endothelial activation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.755
Abstract: Introduction Endothelial Activation and Stress Index (EASIX), a surrogate of endothelial dysfunction, is a powerful tool for predicting non-relapse mortality (NRM) when evaluated prior to allogeneic hematopoietic cell transplantation (allo-HCT) and at specific landmarks post-HCT.…
read more here.
Keywords:
cd34 selected;
allo hct;
easix scores;
relapse ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2018.06.018
Abstract: Most hematological malignancies are increasing in frequency with age. Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapeutic option for patients with malignant and non-malignant hematological diseases. The treatment of elderly patients with advanced…
read more here.
Keywords:
allo hct;
internist know;
know stem;
stem cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Value in Health"
DOI: 10.1016/j.jval.2018.09.1395
Abstract: PIN71 ADENOVIRUS VIREMIA IS AN INDEPENDENT PREDICTOR OF PROLONGED TRANSPLANTATION HOSPITALIZATION IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: FINDINGS FROM ADVANCE Pérez-Martı́nez A, Owens S, Patrick K, Chandak A, Meng J, Brundage T, Vainorius E,…
read more here.
Keywords:
allo hct;
hospitalization;
transplant hospitalization;
adv viremia ... See more keywords